| Year |
Citation |
Score |
| 2024 |
Ocadiz-Ruiz R, Decker JT, Griffin K, Tan ZM, Domala NK, Jeruss JS, Shea LD. Human Breast Cancer Cell Lines Differentially Modulate Signaling from Distant Microenvironments, Which Reflects Their Metastatic Potential. Cancers. 16. PMID 38398186 DOI: 10.3390/cancers16040796 |
0.445 |
|
| 2023 |
Orbach SM, DeVaull CY, Bealer EJ, Ross BC, Jeruss JS, Shea LD. An engineered niche delineates metastatic potential of breast cancer. Bioengineering & Translational Medicine. 9: e10606. PMID 38193115 DOI: 10.1002/btm2.10606 |
0.387 |
|
| 2023 |
Wang J, Ocadiz-Ruiz R, Hall MS, Bushnell GG, Orbach SM, Decker JT, Raghani RM, Zhang Y, Morris AH, Jeruss JS, Shea LD. A synthetic metastatic niche reveals antitumor neutrophils drive breast cancer metastatic dormancy in the lungs. Nature Communications. 14: 4790. PMID 37553342 DOI: 10.1038/s41467-023-40478-5 |
0.394 |
|
| 2023 |
Orbach SM, Brooks MD, Zhang Y, Campit SE, Bushnell GG, Decker JT, Rebernick RJ, Chandrasekaran S, Wicha MS, Jeruss JS, Shea LD. Correction: Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancer. Clinical & Experimental Metastasis. PMID 37310520 DOI: 10.1007/s10585-023-10215-9 |
0.388 |
|
| 2022 |
Orbach SM, Brooks MD, Zhang Y, Campit SE, Bushnell GG, Decker JT, Rebernick RJ, Chandrasekaran S, Wicha MS, Jeruss JS, Shea LD. Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancer. Clinical & Experimental Metastasis. PMID 36002598 DOI: 10.1007/s10585-022-10185-4 |
0.472 |
|
| 2022 |
McCaffrey RL, Thompson JL, Oudsema RH, Sciallis AP, Cobain EF, Sabel MS, Jeruss JS. Management of early stage HER2 positive breast cancer and increased implementation of axillary imaging to improve identification of nodal metastasis. Journal of Surgical Oncology. PMID 35230701 DOI: 10.1002/jso.26840 |
0.377 |
|
| 2021 |
Decker JT, Ma JA, Shea LD, Jeruss JS. Implications of TGFβ Signaling and CDK Inhibition for the Treatment of Breast Cancer. Cancers. 13. PMID 34771508 DOI: 10.3390/cancers13215343 |
0.539 |
|
| 2021 |
Ng S, Sabel MS, Hughes TM, Chang AE, Dossett LA, Jeruss JS. Impact of Breast Cancer Pretreatment Nodal Burden and Disease Subtype on Axillary Surgical Management. The Journal of Surgical Research. 261: 67-73. PMID 33421795 DOI: 10.1016/j.jss.2020.12.007 |
0.316 |
|
| 2021 |
Woodruff TK, Ataman-Millhouse L, Acharya KS, Almeida-Santos T, Anazodo A, Anderson RA, Appiah L, Bader J, Becktell K, Brannigan RE, Breech L, Bourlon MT, Bumbuliene Ž, Burns K, Campo-Engelstein L, ... ... Jeruss JS, et al. A View from the past into our collective future: the oncofertility consortium vision statement. Journal of Assisted Reproduction and Genetics. PMID 33405006 DOI: 10.1007/s10815-020-01983-4 |
0.407 |
|
| 2021 |
Moravek MB, Confino R, Lawson AK, Smith KN, Kazer RR, Klock SC, Gradishar WJ, Jeruss JS, Pavone ME. Predictors and outcomes in breast cancer patients who did or did not pursue fertility preservation. Breast Cancer Research and Treatment. PMID 33392838 DOI: 10.1007/s10549-020-06031-4 |
0.447 |
|
| 2020 |
Bushnell GG, Orbach SM, Ma JA, Crawford HC, Wicha MS, Jeruss JS, Shea LD. Disease-induced immunomodulation at biomaterial scaffolds detects early pancreatic cancer in a spontaneous model. Biomaterials. 269: 120632. PMID 33418200 DOI: 10.1016/j.biomaterials.2020.120632 |
0.375 |
|
| 2020 |
Decker JT, Kandagatla P, Wan L, Bernstein R, Ma JA, Shea LD, Jeruss JS. Cyclin E overexpression confers resistance to trastuzumab through noncanonical phosphorylation of SMAD3 in HER2+ breast cancer. Cancer Biology & Therapy. 1-11. PMID 33054513 DOI: 10.1080/15384047.2020.1818518 |
0.491 |
|
| 2020 |
Wang T, Baskin A, Miller J, Metz A, Matusko N, Hughes T, Sabel M, Jeruss JS, Dossett LA. Trends in Breast Cancer Treatment De-Implementation in Older Patients with Hormone Receptor-Positive Breast Cancer: A Mixed Methods Study. Annals of Surgical Oncology. PMID 32651693 DOI: 10.1245/s10434-020-08823-w |
0.408 |
|
| 2020 |
Shaitelman SF, Jeruss JS, Pusic AL. Oncoplastic Surgery in the Management of Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1902795. PMID 32442070 DOI: 10.1200/JCO.19.02795 |
0.37 |
|
| 2019 |
Bushnell GG, Wicha MS, Jeruss JS, Lonnie D S. Precision health for breast cancer metastasis: biomaterial scaffolds as an engineered metastatic niche to define, study, and monitor metastatic progression. Oncoscience. 6: 380-382. PMID 31984215 DOI: 10.18632/oncoscience.493 |
0.385 |
|
| 2019 |
Bushnell GG, Hong X, Hartfield RM, Zhang Y, Oakes RS, Rao SS, Jeruss JS, Stegemann JP, Deng CX, Shea LD. High Frequency Spectral Ultrasound Imaging to Detect Metastasis in Implanted Biomaterial Scaffolds. Annals of Biomedical Engineering. PMID 31549327 DOI: 10.1007/S10439-019-02366-2 |
0.344 |
|
| 2019 |
Kandagatla P, Shah NM, Jeruss JS. ASO Author Reflections: Challenges in the Management of Young Women with Breast Cancer-Fertility Preservation and Pregnancy. Annals of Surgical Oncology. PMID 30859353 DOI: 10.1245/s10434-019-07285-z |
0.317 |
|
| 2019 |
Bushnell GG, Hardas TP, Hartfield RM, Zhang Y, Oakes RS, Ronquist S, Chen H, Rajapakse I, Wicha MS, Jeruss JS, Shea LD. Biomaterial scaffolds recruit an aggressive population of metastatic tumor cells in vivo. Cancer Research. PMID 30808673 DOI: 10.1158/0008-5472.Can-18-2502 |
0.341 |
|
| 2019 |
Shah NM, Scott DM, Kandagatla P, Moravek MB, Cobain EF, Burness ML, Jeruss JS. Young Women with Breast Cancer: Fertility Preservation Options and Management of Pregnancy-Associated Breast Cancer. Annals of Surgical Oncology. PMID 30680478 DOI: 10.1245/s10434-019-07156-7 |
0.437 |
|
| 2019 |
Kandagatla P, Decker J, Wan L, Bernstein R, Shea L, Jeruss JS. Effect of cyclin E overexpression on resistance to trastuzumab and phosphorylation of SMAD3 in HER2+ breast cancer. Journal of Clinical Oncology. 37: e12006-e12006. DOI: 10.1200/Jco.2019.37.15_Suppl.E12006 |
0.509 |
|
| 2019 |
Kandagatla P, Dokic D, Kochkodan J, Yanik M, Goranta S, Jeruss JS. Noninitiation of Tamoxifen in Young Women at High Risk for Breast Cancer Journal of the American College of Surgeons. 229. DOI: 10.1016/J.Jamcollsurg.2019.08.099 |
0.47 |
|
| 2018 |
Smith BM, Duncan FE, Ataman L, Smith K, Quinn GP, Chang RJ, Finlayson C, Orwig K, Valli-Pulaski H, Moravek MB, Zelinski MB, Irene Su H, Vitek W, Smith JF, Jeruss JS, et al. The National Physicians Cooperative: transforming fertility management in the cancer setting and beyond. Future Oncology (London, England). PMID 30474429 DOI: 10.2217/Fon-2018-0278 |
0.491 |
|
| 2018 |
Rios PD, Kniazeva E, Lee HC, Xiao S, Oakes RS, Saito E, Jeruss JS, Shikanov A, Woodruff TK, Shea LD. Retrievable hydrogels for ovarian follicle transplantation and oocyte collection. Biotechnology and Bioengineering. PMID 29704433 DOI: 10.1002/Bit.26721 |
0.505 |
|
| 2018 |
Constance ES, Moravek MB, Jeruss JS. Strategies to Maintain Fertility in Young Breast Cancer Patients. Cancer Treatment and Research. 173: 1-13. PMID 29349754 DOI: 10.1007/978-3-319-70197-4_1 |
0.408 |
|
| 2018 |
Fragomeni SM, Sciallis A, Jeruss JS. Molecular Subtypes and Local-Regional Control of Breast Cancer. Surgical Oncology Clinics of North America. 27: 95-120. PMID 29132568 DOI: 10.1016/j.soc.2017.08.005 |
0.31 |
|
| 2018 |
Bushnell GG, Hardas TP, Hartfield RM, Zhang Y, Oakes RS, Hong A, Jeruss JS, Shea LD. Abstract 5000: Biomaterial scaffolds that capture metastatic tumor cells in vivo to detect, treat, and study mechanisms of the premetastatic niche and metastasis Tumor Biology. DOI: 10.1158/1538-7445.Am2018-5000 |
0.365 |
|
| 2017 |
Rao SS, Stoehr J, Dokic D, Wan L, Decker JT, Konopka K, Thomas AL, Wu J, Kaklamani VG, Shea LD, Jeruss JS. Synergistic effect of eribulin and CDK inhibition for the treatment of triple negative breast cancer. Oncotarget. 8: 83925-83939. PMID 29137393 DOI: 10.18632/Oncotarget.20202 |
0.616 |
|
| 2017 |
Tarasewicz E, Oakes RS, Aviles MO, Straehla J, Chilton KM, Decker JT, Wu J, Shea LD, Jeruss JS. Embryonic Stem Cell Secreted Factors Decrease Invasiveness of Triple-Negative Breast Cancer Cells Through Regulome Modulation. Cancer Biology & Therapy. 0. PMID 29053396 DOI: 10.1080/15384047.2017.1385681 |
0.798 |
|
| 2017 |
Aguado BA, Bushnell GG, Rao SS, Jeruss JS, Shea LD. Engineering the pre-metastatic niche. Nature Biomedical Engineering. 1. PMID 28989814 DOI: 10.1038/S41551-017-0077 |
0.321 |
|
| 2017 |
Shumway DA, Griffith KA, Sabel MS, Jones RD, Forstner JM, Bott-Kothari TL, Hawley ST, Jeruss J, Jagsi R. Surgeon and Radiation Oncologist Views on Omission of Adjuvant Radiotherapy for Older Women with Early-Stage Breast Cancer. Annals of Surgical Oncology. PMID 28748445 DOI: 10.1245/s10434-017-6013-1 |
0.366 |
|
| 2017 |
Thomas AL, Lind H, Hong A, Dokic D, Oppat K, Rosenthal E, Guo A, Thomas A, Hamden R, Jeruss JS. Inhibition of CDK-mediated Smad3 phosphorylation reduces the Pin1-Smad3 interaction and aggressiveness of triple negative breast cancer cells. Cell Cycle (Georgetown, Tex.). 0. PMID 28678584 DOI: 10.1080/15384101.2017.1338988 |
0.624 |
|
| 2017 |
Decker JT, Hobson EC, Zhang Y, Shin S, Thomas AL, Jeruss JS, Arnold KB, Shea LD. Systems analysis of dynamic transcription factor activity identifies targets for treatment in olaparib resistant cancer cells. Biotechnology and Bioengineering. PMID 28322442 DOI: 10.1002/Bit.26293 |
0.305 |
|
| 2017 |
Thomas A, Hamdan R, Hong A, Lind H, Oppat K, Rosenthal E, Thomas A, Jeruss J. Abstract P3-07-11: Inhibition of Pin1 or CDK-mediated Smad3 phosphorylation reduces triple negative breast cancer cell EMT, migration and invasion Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P3-07-11 |
0.617 |
|
| 2016 |
Vu JV, Llarena NC, Estevez SL, Moravek MB, Jeruss JS. Oncofertility program implementation increases access to fertility preservation options and assisted reproductive procedures for breast cancer patients. Journal of Surgical Oncology. PMID 27966219 DOI: 10.1002/jso.24418 |
0.391 |
|
| 2016 |
Rao SS, Bushnell GG, Azarin SM, Spicer G, Aguado BA, Stoehr JR, Jiang EJ, Backman V, Shea LD, Jeruss JS. Enhanced Survival with Implantable Scaffolds That Capture Metastatic Breast Cancer Cells In Vivo. Cancer Research. 76: 5209-18. PMID 27635043 DOI: 10.1158/0008-5472.Can-15-2106 |
0.399 |
|
| 2016 |
Thomas A, Hamdan R, Hong A, Rosenthal E, Thomas A, Jeruss J. Abstract P5-04-13: Pin1 negatively impacts Smad3 tumor suppression in triple negative breast cancer cell lines Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P5-04-13 |
0.632 |
|
| 2015 |
Kniazeva E, Hardy AN, Boukaidi SA, Woodruff TK, Jeruss JS, Shea LD. Primordial Follicle Transplantation within Designer Biomaterial Grafts Produce Live Births in a Mouse Infertility Model. Scientific Reports. 5: 17709. PMID 26633657 DOI: 10.1038/Srep17709 |
0.438 |
|
| 2015 |
Azarin SM, Yi J, Gower RM, Aguado BA, Sullivan ME, Goodman AG, Jiang EJ, Rao SS, Ren Y, Tucker SL, Backman V, Jeruss JS, Shea LD. In vivo capture and label-free detection of early metastatic cells. Nature Communications. 6: 8094. PMID 26348915 DOI: 10.1038/Ncomms9094 |
0.317 |
|
| 2015 |
Llarena NC, Estevez SL, Tucker SL, Jeruss JS. Impact of Fertility Concerns on Tamoxifen Initiation and Persistence. Journal of the National Cancer Institute. 107. PMID 26307641 DOI: 10.1093/jnci/djv202 |
0.348 |
|
| 2015 |
Kaklamani VG, Jeruss JS, Hughes E, Siziopikou K, Timms KM, Gutin A, Abkevich V, Sangale Z, Solimeno C, Brown KL, Jones J, Hartman AR, Meservey C, Jovanovic B, Helenowski I, et al. Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579). Breast Cancer Research and Treatment. 151: 629-38. PMID 26006067 DOI: 10.1007/S10549-015-3435-Y |
0.404 |
|
| 2015 |
Petersen LF, Jeruss JS. Nottingham Clinico-Pathological Response Index (NPRI) after Neoadjuvant Chemotherapy (Neo-ACT) Accurately Predicts Clinical Outcome in Locally Advanced Breast Cancer Breast Diseases. 26: 314-315. DOI: 10.1016/j.breastdis.2015.10.029 |
0.34 |
|
| 2014 |
Khavanin N, Kim JY, Davila AA, Ver Halen JP, Mlodinow AS, Bethke KP, Khan SA, Jeruss JS, Hansen NM, Bilimoria KY, Losken A, Fine NA. Abstract 46: The BRA Score: Creating a General Risk Calculator for Breast Reconstruction Outcomes. Plastic and Reconstructive Surgery. 133: 56-7. PMID 25942157 DOI: 10.1097/01.Prs.0000445079.93837.65 |
0.364 |
|
| 2014 |
Tarasewicz E, Rivas L, Hamdan R, Dokic D, Parimi V, Bernabe BP, Thomas A, Shea LD, Jeruss JS. Inhibition of CDK-mediated phosphorylation of Smad3 results in decreased oncogenesis in triple negative breast cancer cells. Cell Cycle (Georgetown, Tex.). 13: 3191-201. PMID 25485498 DOI: 10.4161/15384101.2014.950126 |
0.834 |
|
| 2014 |
Weiss MS, Peñalver Bernabé B, Shin S, Asztalos S, Dubbury SJ, Mui MD, Bellis AD, Bluver D, Tonetti DA, Saez-Rodriguez J, Broadbelt LJ, Jeruss JS, Shea LD. Dynamic transcription factor activity and networks during ErbB2 breast oncogenesis and targeted therapy. Integrative Biology : Quantitative Biosciences From Nano to Macro. 6: 1170-82. PMID 25303361 DOI: 10.1039/C4Ib00086B |
0.473 |
|
| 2014 |
Lee O, Page K, Ivancic D, Helenowski I, Parini V, Sullivan ME, Margenthaler JA, Chatterton RT, Jovanovic B, Dunn BK, Heckman-Stoddard BM, Foster K, Muzzio M, Shklovskaya J, Skripkauskas S, ... ... Jeruss JS, et al. A randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in situ of the breast. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 3672-82. PMID 25028506 DOI: 10.1158/1078-0432.Ccr-13-3045 |
0.341 |
|
| 2014 |
Tarasewicz E, Hamdan R, Straehla J, Hardy A, Nunez O, Zelivianski S, Dokic D, Jeruss JS. CDK4 inhibition and doxorubicin mediate breast cancer cell apoptosis through Smad3 and survivin. Cancer Biology & Therapy. 15: 1301-11. PMID 25006666 DOI: 10.4161/Cbt.29693 |
0.816 |
|
| 2014 |
Khavanin N, Bethke KP, Lovecchio FC, Jeruss JS, Hansen NM, Kim JY. Risk factors for unplanned readmissions following excisional breast surgery. The Breast Journal. 20: 288-94. PMID 24689860 DOI: 10.1111/Tbj.12253 |
0.306 |
|
| 2014 |
Rakhra S, Bethke K, Strauss J, Hayes J, Hansen N, Khan S, Jeruss J, Helenowski I, Donnelly E. Review of Outcomes After Breast-Conserving Surgery and Intraoperative Radiation Therapy and Risk Factors Leading to Breast Complications for Early-Stage Breast Cancer International Journal of Radiation Oncology*Biology*Physics. 90: S230. DOI: 10.1016/J.Ijrobp.2014.05.822 |
0.481 |
|
| 2013 |
Cameron KA, Stolley M, Bethke KP, Hansen NM, Jeruss JS, Clayman ML, Khan SA. Breast cancer patients' risk perceptions and treatment values following surgical consult. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 36. PMID 28136620 DOI: 10.1200/jco.2013.31.26_suppl.36 |
0.431 |
|
| 2013 |
Saha D, Davila AA, Ver Halen JP, Jain UK, Hansen N, Bethke K, Khan SA, Jeruss J, Fine N, Kim jY. Post-mastectomy reconstruction: a risk-stratified comparative analysis of outcomes. Breast (Edinburgh, Scotland). 22: 1072-80. PMID 24354013 DOI: 10.1016/J.Breast.2013.09.010 |
0.364 |
|
| 2013 |
Siletz A, Schnabel M, Kniazeva E, Schumacher AJ, Shin S, Jeruss JS, Shea LD. Dynamic transcription factor networks in epithelial-mesenchymal transition in breast cancer models. Plos One. 8: e57180. PMID 23593114 DOI: 10.1371/Journal.Pone.0057180 |
0.451 |
|
| 2013 |
Gracia CR, Jeruss JS. Lives in the balance: women with cancer and the right to fertility care. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 668-9. PMID 23341520 DOI: 10.1200/Jco.2012.47.5798 |
0.376 |
|
| 2013 |
Pilewskie M, Kennedy C, Shappell C, Helenowski I, Scholtens D, Hansen N, Bethke K, Jeruss J, Karstaedt P, Khan SA. Effect of MRI on the management of ductal carcinoma in situ of the breast. Annals of Surgical Oncology. 20: 1522-9. PMID 23224903 DOI: 10.1245/S10434-012-2771-Y |
0.343 |
|
| 2013 |
Siletz A, Kniazeva E, Jeruss JS, Shea LD. Transcription factor networks in invasion-promoting breast carcinoma-associated fibroblasts. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 6: 91-107. PMID 23090154 DOI: 10.1007/S12307-012-0121-Z |
0.539 |
|
| 2013 |
Giordano SB, Rao S, Hamdan R, Jeruss J, Bethke K, Hansen N, Khan S, Roenn JV, Rosen S, Gradishar WJ, Siziopikou K, Meservey C, Kaklamani V. Abstract A065: Neoadjuvant phase II trial with eribulin and carboplatin in patients with triple-negative breast cancer Molecular Cancer Research. 11. DOI: 10.1158/1557-3125.Advbc-A065 |
0.474 |
|
| 2013 |
Tarasewicz E, Rivas L, Hamdan R, Shea L, Jeruss J. Abstract P6-04-12: CDK inhibition mediates tumor suppressive Smad3 action and decreased metastatic phenotypes in triple negative breast cancer cells Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P6-04-12 |
0.833 |
|
| 2013 |
Hamdan R, Jeruss J. Abstract P5-11-01: Impact of CDK mediated Smad3 phosphorylation and Pin1 in triple negative breast cancer cell migration Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P5-11-01 |
0.65 |
|
| 2013 |
Giordano S, Jeruss J, Bethke K, Hansen N, Khan S, Roenn JV, Rosen S, Gradishar W, Siziopikou K, Meservey C, Kaklamani V. Abstract P3-14-14: Neoadjuvant phase II trial with carboplatin and eribulin in triple negative breast cancer patients Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P3-14-14 |
0.385 |
|
| 2013 |
Hamdan R, Tarasewicz E, Nunez O, Straehla J, Hardy A, Zelivianski S, Jeruss J. Combined CDK4 Inhibition and Doxorubicin Restores Smad3 Tumor Suppression and Induces Apoptosis Via a Survivin-Associated Mechanism Journal of Surgical Research. 179: 341. DOI: 10.1016/J.Jss.2012.10.800 |
0.741 |
|
| 2013 |
Tarasewicz E, Rivas L, Jeruss J. Inhibition of CDK Mediated Smad3 Phosphorylation Results in Decreased Oncogenic Phenotypes in Triple Negative Breast Cancer Cells Journal of Surgical Research. 179: 254-255. DOI: 10.1016/J.Jss.2012.10.482 |
0.829 |
|
| 2013 |
Llarena N, Nlez O, Jeruss J. Impact of Fertility Concerns on Tamoxifen Adherence in Young Women With Breast Cancer Journal of Surgical Research. 179: 254. DOI: 10.1016/J.Jss.2012.10.481 |
0.493 |
|
| 2012 |
Foucar CE, Hardy A, Siziopikou KP, Wang L, Parini V, Hansen N, Jeruss JS. A mother and daughter with phyllodes tumors of the breast. Clinical Breast Cancer. 12: 373-7. PMID 22981939 DOI: 10.1016/J.Clbc.2012.07.011 |
0.394 |
|
| 2012 |
Tarasewicz E, Jeruss JS. Phospho-specific Smad3 signaling: impact on breast oncogenesis. Cell Cycle (Georgetown, Tex.). 11: 2443-51. PMID 22659843 DOI: 10.4161/Cc.20546 |
0.816 |
|
| 2012 |
Boukaidi SA, Cooley A, Hardy A, Matthews L, Zelivianski S, Jeruss JS. Impact of infertility regimens on breast cancer cells: follicle-stimulating hormone and luteinizing hormone lack a direct effect on breast cell proliferation in vitro. Fertility and Sterility. 97: 440-4. PMID 22188984 DOI: 10.1016/J.Fertnstert.2011.11.020 |
0.56 |
|
| 2012 |
Cooley A, Matthews L, Zelivianski S, Hardy A, Jeruss JS. Effect of infertility treatment and pregnancy-related hormones on breast cell proliferation in vitro. Human Reproduction (Oxford, England). 27: 146-52. PMID 22081245 DOI: 10.1093/Humrep/Der378 |
0.572 |
|
| 2012 |
Pilewskie M, Gorodinsky P, Fought A, Hansen N, Bethke K, Jeruss J, Scholtens D, Khan SA. Association between recency of last pregnancy and biologic subtype of breast cancer. Annals of Surgical Oncology. 19: 1167-73. PMID 21997350 DOI: 10.1245/S10434-011-2104-6 |
0.491 |
|
| 2012 |
Kaklamani VG, Siziopikou K, Scholtens D, Lacouture M, Gordon J, Uthe R, Meservey C, Hansen N, Khan SA, Jeruss JS, Bethke K, Cianfrocca M, Rosen S, Von Roenn J, Wayne J, et al. Pilot neoadjuvant trial in HER2 positive breast cancer with combination of nab-paclitaxel and lapatinib. Breast Cancer Research and Treatment. 132: 833-42. PMID 21359953 DOI: 10.1007/S10549-011-1411-8 |
0.484 |
|
| 2012 |
Tarasewicz E, Aviles M, Shea LD, Jeruss JS. Abstract 3241: Analysis of transcription factor activation by the embryonic microenvironment in metastatic breast cancer cells Cancer Research. 72: 3241-3241. DOI: 10.1158/1538-7445.Am2012-3241 |
0.782 |
|
| 2012 |
Tarasewicz E, Hardy A, Zelivianski S, Jeruss J. Impact of CDK4 Inhibition and Chemotherapy on Smad3 Action in Breast Cancer Cell Proliferation and Migration Journal of Surgical Research. 172: 229-230. DOI: 10.1016/J.Jss.2011.11.347 |
0.825 |
|
| 2012 |
Hardy A, Boukaidi S, Shea L, Jeruss J. Fertility Preservation in Young Cancer Patients: Transplantation of Isolated Ovarian Follicles in Biomaterials in a Mouse Model of Infertility Journal of Surgical Research. 172: 194. DOI: 10.1016/J.Jss.2011.11.139 |
0.338 |
|
| 2012 |
Spiguel L, Jeruss J. Impact of breast surgery on survival in women presenting with metastatic breast cancer Breast Diseases: a Year Book Quarterly. 23: 257-258. DOI: 10.1016/J.BREASTDIS.2012.06.023 |
0.403 |
|
| 2011 |
Eladoumikdachi FG, Jones M, Shidfar A, Helenowski IB, Franz JM, Scholtens D, Sullivan ME, Bethke KP, Hansen NM, Jeruss JS, Khan SA. Prognostic classification of ipsilateral breast tumor recurrence (IBTR). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 137. PMID 27958141 DOI: 10.1200/jco.2011.29.27_suppl.137 |
0.303 |
|
| 2011 |
Brutus V, McGathey C, Kmiecik T, Bethke KP, Jeruss JS, Hansen NM, Khan SA. Breast cancer characteristics in yielders and nonyielders of nipple aspiration fluid. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 71. PMID 27958098 DOI: 10.1200/jco.2011.29.27_suppl.71 |
0.419 |
|
| 2011 |
Revesz E, Zalles CM, Ivancic D, Bethke KP, Hansen NM, Jeruss JS, Khan SA. Relationship of recent pregnancy and cytologic atypia in the contralateral breast of patients with breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 149. PMID 27958004 DOI: 10.1200/jco.2011.29.27_suppl.149 |
0.425 |
|
| 2011 |
Mittendorf EA, Jeruss JS, Tucker SL, Kolli A, Newman LA, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KK. Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1956-62. PMID 21482989 DOI: 10.1200/JCO.2010.31.8469 |
0.328 |
|
| 2011 |
Hulvat MC, Jeruss JS. Fertility preservation options for young women with breast cancer. Current Opinion in Obstetrics & Gynecology. 23: 174-82. PMID 21415746 DOI: 10.1097/Gco.0B013E328345525A |
0.485 |
|
| 2011 |
Goyal S, Vicini F, Beitsch PD, Kuerer H, Keisch M, Motwani S, Jeruss JS, Lyden M, Haffty BG. Ductal carcinoma in situ treated with breast-conserving surgery and accelerated partial breast irradiation: comparison of the Mammosite registry trial with intergroup study E5194. Cancer. 117: 1149-55. PMID 21381007 DOI: 10.1002/Cncr.25615 |
0.439 |
|
| 2011 |
Redig AJ, Brannigan R, Stryker SJ, Woodruff TK, Jeruss JS. Incorporating fertility preservation into the care of young oncology patients. Cancer. 117: 4-10. PMID 21235031 DOI: 10.1002/Cncr.25398 |
0.574 |
|
| 2011 |
Bellis AD, Peňalver-Bernabé B, Weiss MS, Yarrington ME, Barbolina MV, Pannier AK, Jeruss JS, Broadbelt LJ, Shea LD. Cellular arrays for large-scale analysis of transcription factor activity Biotechnology and Bioengineering. 108: 395-403. PMID 20812256 DOI: 10.1002/Bit.22916 |
0.387 |
|
| 2011 |
Jeruss JS, Kuerer HM, Beitsch PD, Vicini FA, Keisch M. Update on DCIS outcomes from the American Society of Breast Surgeons accelerated partial breast irradiation registry trial. Annals of Surgical Oncology. 18: 65-71. PMID 20577822 DOI: 10.1245/S10434-010-1192-Z |
0.437 |
|
| 2011 |
Tarasewicz E, Hardy A, Straehla J, Foucar C, Zelivianski S, Jeruss J. P2-02-06: Inhibition of CDK4 Phosphorylation of Smad3 Decreases Cyclin D Overexpressing Breast Cancer Cell Proliferation and Migration. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P2-02-06 |
0.819 |
|
| 2010 |
Cooley A, Zelivianski S, Jeruss JS. Impact of cyclin E overexpression on Smad3 activity in breast cancer cell lines. Cell Cycle (Georgetown, Tex.). 9: 4900-7. PMID 21150326 DOI: 10.4161/Cc.9.24.14158 |
0.626 |
|
| 2010 |
Weiss MS, Bernabé BP, Bellis AD, Broadbelt LJ, Jeruss JS, Shea LD. Dynamic, large-scale profiling of transcription factor activity from live cells in 3d culture Plos One. 5. PMID 21103341 DOI: 10.1371/Journal.Pone.0014026 |
0.395 |
|
| 2010 |
Jeruss JS. Discussing fertility preservation with breast cancer patients. Cancer Treatment and Research. 156: 461-6. PMID 20811855 DOI: 10.1007/978-1-4419-6518-9_35 |
0.493 |
|
| 2010 |
Zelivianski S, Cooley A, Kall R, Jeruss JS. Cyclin-dependent kinase 4-mediated phosphorylation inhibits Smad3 activity in cyclin D-overexpressing breast cancer cells. Molecular Cancer Research : McR. 8: 1375-87. PMID 20736297 DOI: 10.1158/1541-7786.Mcr-09-0537 |
0.619 |
|
| 2010 |
Gardino SL, Jeruss JS, Woodruff TK. Using decision trees to enhance interdisciplinary team work: the case of oncofertility. Journal of Assisted Reproduction and Genetics. 27: 227-31. PMID 20386978 DOI: 10.1007/S10815-010-9413-8 |
0.513 |
|
| 2010 |
Abbott DE, Margaryan NV, Jeruss JS, Khan S, Kaklamani V, Winchester DJ, Hansen N, Rademaker A, Khalkhali-Ellis Z, Hendrix MJ. Reevaluating cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathology. Cancer Biology & Therapy. 9: 23-30. PMID 19923884 DOI: 10.4161/Cbt.9.1.10378 |
0.493 |
|
| 2010 |
Hulvat MC, Jeruss JS. Fertility Preservation Options for Patients with Cancer European Oncology and Haematology. 6: 31. DOI: 10.17925/Eoh.2010.06.1.31 |
0.404 |
|
| 2010 |
Jeruss JS. Kuererʼs Breast Surgical Oncology Annals of Surgery. 252: 408. DOI: 10.1097/sla.0b013e3181e98708 |
0.348 |
|
| 2009 |
Hulvat MC, Jeruss JS. Maintaining fertility in young women with breast cancer. Current Treatment Options in Oncology. 10: 308-17. PMID 20238254 DOI: 10.1007/S11864-010-0116-2 |
0.468 |
|
| 2009 |
Mangat A, Schiller C, Mengoni P, Reynolds C, Jeruss JS. Calcifying fibrous pseudotumor of the breast. The Breast Journal. 15: 299-301. PMID 19645787 DOI: 10.1111/J.1524-4741.2009.00721.X |
0.426 |
|
| 2009 |
Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. The New England Journal of Medicine. 360: 902-11. PMID 19246362 DOI: 10.1056/Nejmra0801454 |
0.526 |
|
| 2009 |
Hulvat MC, Hansen NM, Jeruss JS. Multidisciplinary care for patients with breast cancer. The Surgical Clinics of North America. 89: 133-76, ix. PMID 19186235 DOI: 10.1016/J.Suc.2008.10.002 |
0.473 |
|
| 2009 |
Zelivianski S, Cooley A, Jeruss J. Cyclin overexpression inhibits Smad 3 tumor suppression in breast cancer cells. Cancer Research. 69: 5033. DOI: 10.1158/0008-5472.Sabcs-5033 |
0.597 |
|
| 2009 |
Goyal S, Vicini F, Beitsch P, Keisch M, Jeruss J, Lyden M, Haffty B. Low Risk Ductal Carcinoma In Situ (DCIS) Treated with Breast Conserving Surgery & Accelerated Partial Breast Irradation (APBI): Comparison of the Mammosite Registry Trial with Intergroup Study E5194. Cancer Research. 69: 951-951. DOI: 10.1158/0008-5472.Sabcs-09-951 |
0.367 |
|
| 2009 |
Zelivianski S, Cooley A, Jeruss J. CDK4 Phosphorylation Regulates Smad3 Activity in Cyclin D1 Overexpressing Breast Cancer Cells. Cancer Research. 69: 2152-2152. DOI: 10.1158/0008-5472.Sabcs-09-2152 |
0.556 |
|
| 2009 |
Kaklamani V, Uthe R, Khan S, Hansen N, Bethke K, Jeruss J, Cianfrocca M, Roenn JV, Rosen S, Gradishar W. Pilot Neoadjuvant Trial with Combination of Lapatinib and Nab-Paclitaxel in HER2+ Breast Cancer. Cancer Research. 69: 1091-1091. DOI: 10.1158/0008-5472.Sabcs-09-1091 |
0.5 |
|
| 2009 |
Hulvat M, Jeruss J. Axillary Staging Prior to Neoadjuvant Chemotherapy for Breast Cancer: Predictors of Recurrence Breast Diseases: a Year Book Quarterly. 20: 177-179. DOI: 10.1016/S1043-321X(09)79279-3 |
0.408 |
|
| 2009 |
Zelivianski S, Kall R, Cooley A, Jeruss J. 42: The Effect of Cyclin D Overexpression on Smad 3 Action in Breast Cancer Cells Journal of Surgical Research. 151: 190-191. DOI: 10.1016/J.Jss.2008.11.069 |
0.59 |
|
| 2008 |
Ghosh S, Bryce KS, Jeruss JS. Effects of activin and cyclin overexpression on Smad 3 function in breast cancer cells. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 22072. PMID 27950534 DOI: 10.1200/jco.2008.26.15_suppl.22072 |
0.566 |
|
| 2008 |
Jeruss JS, Mittendorf EA, Tucker SL, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KK. Staging of breast cancer in the neoadjuvant setting. Cancer Research. 68: 6477-81. PMID 18701468 DOI: 10.1158/0008-5472.Can-07-6520 |
0.483 |
|
| 2008 |
Jeruss JS, Mittendorf EA, Tucker SL, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KK. Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 246-52. PMID 18056680 DOI: 10.1200/JCO.2007.11.5352 |
0.384 |
|
| 2008 |
Ghosh S, Fitzgerald K, Bryce KS, Jeruss JS. QS283. Effect of Activin ond Smad 3 Signal Transduction on Breast Cancer Cell Lines Journal of Surgical Research. 144: 379. DOI: 10.1016/j.jss.2007.12.534 |
0.483 |
|
| 2006 |
Jeruss JS, Vicini FA, Beitsch PD, Haffty BG, Quiet CA, Zannis VJ, Keleher AJ, Garcia DM, Snider HC, Gittleman MA, Whitacre E, Whitworth PW, Fine RE, Arrambide S, Kuerer HM. Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical trial for ductal carcinoma-in-situ of the breast. Annals of Surgical Oncology. 13: 967-76. PMID 16788759 DOI: 10.1245/ASO.2006.08.031 |
0.323 |
|
| 2005 |
Jeruss JS, Kuerer HM. Bone marrow micrometastases in breast cancer. The New England Journal of Medicine. 353: 2191; author reply 2. PMID 16291991 DOI: 10.1056/NEJM200511173532016 |
0.351 |
|
| 2005 |
Burdette JE, Jeruss JS, Kurley SJ, Lee EJ, Woodruff TK. Activin A mediates growth inhibition and cell cycle arrest through Smads in human breast cancer cells. Cancer Research. 65: 7968-75. PMID 16140969 DOI: 10.1158/0008-5472.Can-04-3553 |
0.714 |
|
| 2005 |
Jeruss JS, Winchester DJ, Sener SF, Brinkmann EM, Bilimoria MM, Barrera E, Alwawi E, Nickolov A, Schermerhorn GM, Winchester DJ. Axillary recurrence after sentinel node biopsy. Annals of Surgical Oncology. 12: 34-40. PMID 15827776 DOI: 10.1007/S10434-004-1164-2 |
0.343 |
|
| 2004 |
Jeruss JS, Lee EJ, Rademaker AW, Woodruff TK. Activin and smad 3 supression of breast cancer cell cycle progression Annals of Surgical Oncology. 11: S87-S87. DOI: 10.1007/Bf02524079 |
0.707 |
|
| 2003 |
Jeruss JS, Sturgis CD, Rademaker AW, Woodruff TK. Down-regulation of activin, activin receptors, and Smads in high-grade breast cancer. Cancer Research. 63: 3783-90. PMID 12839974 |
0.622 |
|
| 2003 |
Jeruss JS, Santiago JY, Woodruff TK. Localization of activin and inhibin subunits, receptors and SMADs in the mouse mammary gland. Molecular and Cellular Endocrinology. 203: 185-96. PMID 12782414 DOI: 10.1016/S0303-7207(02)00291-5 |
0.723 |
|
| 2003 |
Jeruss JS, Liu NX, Chung Y, Magrane G, Waldman F, Edgerton S, Yang X, Thor AD. Characterization and chromosomal instability of novel derived cell lines from a wt-erbB-2 transgenic mouse model. Carcinogenesis. 24: 659-64. PMID 12727793 DOI: 10.1093/Carcin/Bgg001 |
0.342 |
|
| 2001 |
Pappas SG, Jeruss JS, Talamonti MS. Clinical features of primary and metastatic hepatic malignancies Cancer Treatment and Research. 109: 1-14. PMID 11775430 DOI: 10.1007/978-1-4757-3371-6_1 |
0.363 |
|
| 1999 |
Jeruss JS. Breast cancer: molecular genetics, pathogenesis, and therapeutics. edited by Anne M Bowcock. 582 pages, illustrated. $145.00. Totowa, NJ: Humana Press, 1999. Journal of the American College of Surgeons. 189: 640-641. DOI: 10.1016/S1072-7515(99)00204-5 |
0.374 |
|
| Show low-probability matches. |